OTCMKTS:ETAH

Eternity Healthcare Competitors

$0.0030
0.00 (0.00 %)
(As of 04/22/2021 12:00 AM ET)
Add
Compare
Today's Range
$0.00
Now: $0.00
$0.00
50-Day Range N/A
52-Week Range
$0.00
Now: $0.00
$0.03
Volume1.18 million shs
Average Volume313,935 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Competitors

Eternity Healthcare (OTCMKTS:ETAH) Vs. OLK, OCDX, BDSX, LHDX, AKU, and NOTV

Should you be buying ETAH stock or one of its competitors? Companies in the industry of "diagnostics & research" are considered alternatives and competitors to Eternity Healthcare, including Olink Holding AB (publ) (OLK), Ortho Clinical Diagnostics (OCDX), Biodesix (BDSX), Lucira Health (LHDX), Akumin (AKU), and Inotiv (NOTV).

Eternity Healthcare (OTCMKTS:ETAH) and Olink Holding AB (publ) (NASDAQ:OLK) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, earnings, analyst recommendations, dividends, valuation, institutional ownership and profitability.

Analyst Recommendations

This is a summary of recent ratings and recommmendations for Eternity Healthcare and Olink Holding AB (publ), as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Eternity Healthcare0000N/A
Olink Holding AB (publ)02202.50

Olink Holding AB (publ) has a consensus price target of $44.00, suggesting a potential upside of 12.94%. Given Olink Holding AB (publ)'s higher probable upside, analysts clearly believe Olink Holding AB (publ) is more favorable than Eternity Healthcare.

Profitability

This table compares Eternity Healthcare and Olink Holding AB (publ)'s net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Eternity HealthcareN/AN/AN/A
Olink Holding AB (publ)N/AN/AN/A

Earnings and Valuation

This table compares Eternity Healthcare and Olink Holding AB (publ)'s gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Eternity HealthcareN/AN/AN/AN/AN/A
Olink Holding AB (publ)N/AN/AN/AN/AN/A

Summary

Olink Holding AB (publ) beats Eternity Healthcare on 2 of the 2 factors compared between the two stocks.

Eternity Healthcare (OTCMKTS:ETAH) and Ortho Clinical Diagnostics (NASDAQ:OCDX) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their risk, analyst recommendations, dividends, profitability, valuation, institutional ownership and earnings.

Analyst Recommendations

This is a summary of current ratings and target prices for Eternity Healthcare and Ortho Clinical Diagnostics, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Eternity Healthcare0000N/A
Ortho Clinical Diagnostics011102.92

Ortho Clinical Diagnostics has a consensus target price of $24.2727, suggesting a potential upside of 20.40%. Given Ortho Clinical Diagnostics' higher probable upside, analysts clearly believe Ortho Clinical Diagnostics is more favorable than Eternity Healthcare.

Earnings & Valuation

This table compares Eternity Healthcare and Ortho Clinical Diagnostics' top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Eternity HealthcareN/AN/AN/AN/AN/A
Ortho Clinical DiagnosticsN/AN/AN/AN/AN/A

Profitability

This table compares Eternity Healthcare and Ortho Clinical Diagnostics' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Eternity HealthcareN/AN/AN/A
Ortho Clinical DiagnosticsN/AN/AN/A

Summary

Ortho Clinical Diagnostics beats Eternity Healthcare on 2 of the 2 factors compared between the two stocks.

Biodesix (NASDAQ:BDSX) and Eternity Healthcare (OTCMKTS:ETAH) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their earnings, profitability, dividends, analyst recommendations, valuation, institutional ownership and risk.

Analyst Ratings

This is a summary of recent ratings and price targets for Biodesix and Eternity Healthcare, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Biodesix00403.00
Eternity Healthcare0000N/A

Biodesix currently has a consensus target price of $26.00, suggesting a potential upside of 43.41%. Given Biodesix's higher possible upside, equities analysts clearly believe Biodesix is more favorable than Eternity Healthcare.

Profitability

This table compares Biodesix and Eternity Healthcare's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
BiodesixN/AN/AN/A
Eternity HealthcareN/AN/AN/A

Valuation & Earnings

This table compares Biodesix and Eternity Healthcare's revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
BiodesixN/AN/AN/AN/AN/A
Eternity HealthcareN/AN/AN/AN/AN/A

Summary

Biodesix beats Eternity Healthcare on 2 of the 2 factors compared between the two stocks.

Lucira Health (NASDAQ:LHDX) and Eternity Healthcare (OTCMKTS:ETAH) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their dividends, profitability, institutional ownership, earnings, valuation, risk and analyst recommendations.

Profitability

This table compares Lucira Health and Eternity Healthcare's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Lucira HealthN/AN/AN/A
Eternity HealthcareN/AN/AN/A

Earnings & Valuation

This table compares Lucira Health and Eternity Healthcare's top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Lucira HealthN/AN/AN/AN/AN/A
Eternity HealthcareN/AN/AN/AN/AN/A

Analyst Ratings

This is a summary of recent ratings for Lucira Health and Eternity Healthcare, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Lucira Health10202.33
Eternity Healthcare0000N/A

Lucira Health presently has a consensus price target of $9.00, indicating a potential upside of 29.31%. Given Lucira Health's higher probable upside, research analysts clearly believe Lucira Health is more favorable than Eternity Healthcare.

Summary

Lucira Health beats Eternity Healthcare on 2 of the 2 factors compared between the two stocks.

Akumin (NASDAQ:AKU) and Eternity Healthcare (OTCMKTS:ETAH) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their earnings, risk, institutional ownership, dividends, profitability, valuation and analyst recommendations.

Insider and Institutional Ownership

30.4% of Akumin shares are held by institutional investors. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Valuation and Earnings

This table compares Akumin and Eternity Healthcare's gross revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
AkuminN/AN/AN/AN/AN/A
Eternity HealthcareN/AN/AN/AN/AN/A

Profitability

This table compares Akumin and Eternity Healthcare's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
AkuminN/AN/AN/A
Eternity HealthcareN/AN/AN/A

Analyst Ratings

This is a summary of recent recommendations for Akumin and Eternity Healthcare, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Akumin00103.00
Eternity Healthcare0000N/A

Summary

Akumin beats Eternity Healthcare on 2 of the 2 factors compared between the two stocks.

Eternity Healthcare (OTCMKTS:ETAH) and Inotiv (NASDAQ:NOTV) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, analyst recommendations, valuation, profitability, earnings, dividends and risk.

Profitability

This table compares Eternity Healthcare and Inotiv's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Eternity HealthcareN/AN/AN/A
InotivN/AN/AN/A

Earnings & Valuation

This table compares Eternity Healthcare and Inotiv's gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Eternity HealthcareN/AN/AN/AN/AN/A
InotivN/AN/AN/AN/AN/A

Analyst Ratings

This is a breakdown of recent recommendations and price targets for Eternity Healthcare and Inotiv, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Eternity Healthcare0000N/A
Inotiv0000N/A


Eternity Healthcare Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
OLK
Olink Holding AB (publ)
1.0$38.96flat$4.57 billionN/A0.00Analyst Revision
Ortho Clinical Diagnostics logo
OCDX
Ortho Clinical Diagnostics
1.6$20.16flat$4.52 billionN/A0.00Unusual Options Activity
Biodesix logo
BDSX
Biodesix
1.6$18.13flat$485.58 millionN/A0.00Lockup Expiration
Lucira Health logo
LHDX
Lucira Health
1.5$6.97flat$273.60 millionN/A0.00
Akumin logo
AKU
Akumin
0.6$3.15flat$216.86 millionN/A0.00
NOTV
Inotiv
0.0$20.68flat$210.38 millionN/A0.00News Coverage
Gap Down
Relay Medical logo
RYMDF
Relay Medical
0.0$0.35flat$51.25 millionN/A0.00Gap Down
Global WholeHealth Partners logo
GWHP
Global WholeHealth Partners
0.0$0.59flat$40.12 millionN/A0.00
Epigenomics logo
EPGNY
Epigenomics
0.6$12.39flat$0.00N/A0.00News Coverage
MEDD
Medical Imaging
0.4$0.01flat$0.00N/A0.00
Parallax Health Sciences logo
PRLX
Parallax Health Sciences
0.5$0.01flat$0.00N/A0.00
Siemens Healthineers logo
SMMNY
Siemens Healthineers
0.5$29.28flat$0.00N/A0.00
WUXIF
WuXi AppTec
1.0$19.88flat$0.00N/A0.00
This page was last updated on 4/23/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.